Agarwal A, Wehrle C, Satish S, Mahajan P, Kamath S, Koyfman S
Biomedicines. 2025; 13(1).
PMID: 39857707
PMC: 11762135.
DOI: 10.3390/biomedicines13010123.
Ewijk R, Dandis R, Rodewijk J, de Keizer B, Ter Horst S, van de Sande M
Eur Radiol. 2025; .
PMID: 39853333
DOI: 10.1007/s00330-025-11372-z.
McAteer M, McGowan D, Cook G, Leung H, Ng T, OConnor J
BMC Med. 2025; 23(1):37.
PMID: 39849494
PMC: 11756105.
DOI: 10.1186/s12916-024-03831-z.
de Ruiter R, Zwama J, Raijmakers P, Yaqub M, Burchell G, Boellaard R
Ann Nucl Med. 2024; 39(2):98-149.
PMID: 39729191
PMC: 11799077.
DOI: 10.1007/s12149-024-01991-9.
Parodi D, Dighero E, Biddau G, DAmico F, Bauckneht M, Marini C
EJNMMI Res. 2024; 14(1):102.
PMID: 39485534
PMC: 11530415.
DOI: 10.1186/s13550-024-01161-y.
Estimation of liver standardized uptake value in F18-FDG PET/CT scanning: impact of different malignancies, blood glucose level, body weight normalization, and imaging systems.
Abd-Elkader M, Elmaghraby S, Abdel-Mohsen M, Khalil M
Ann Nucl Med. 2024; 39(2):176-188.
PMID: 39412606
PMC: 11799010.
DOI: 10.1007/s12149-024-01985-7.
A Review on the Use of Imaging Biomarkers in Oncology Clinical Trials: Quality Assurance Strategies for Technical Validation.
Chauvie S, Mazzoni L, ODoherty J
Tomography. 2023; 9(5):1876-1902.
PMID: 37888741
PMC: 10610870.
DOI: 10.3390/tomography9050149.
Recent Advances of S-F Radiochemistry for Positron Emission Tomography.
Deng X, Zhu X
ACS Omega. 2023; 8(41):37720-37730.
PMID: 37867643
PMC: 10586020.
DOI: 10.1021/acsomega.3c05594.
Different hydration protocols for the quantification of healthy tissue uptake of half-dose F-FDG total-body positron emission tomography-computed tomography: a prospective study.
Cao Y, Cai D, Sui X, Wang X, Song J, Tan H
Quant Imaging Med Surg. 2023; 13(9):5701-5712.
PMID: 37711806
PMC: 10498230.
DOI: 10.21037/qims-22-440.
Early prediction of treatment outcome for lenvatinib using F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study.
Takeuchi S, Hirata K, Magota K, Watanabe S, Moku R, Shiiya A
EJNMMI Res. 2023; 13(1):69.
PMID: 37460834
PMC: 10352209.
DOI: 10.1186/s13550-023-01019-9.
Optimal Management of Insulin in Patients Undergoing 18F-Fluorodeoxyglucose Positron Emission Tomography Scans.
Seth S, Gallagher E
Endocr Pract. 2023; 29(9):705-709.
PMID: 37369292
PMC: 10529812.
DOI: 10.1016/j.eprac.2023.06.006.
Repeatability of metabolic tumor burden and lesion glycolysis between clinical readers.
Choi J, Dean E, Lu H, Thompson Z, Qi J, Krivenko G
Front Immunol. 2023; 14:994520.
PMID: 36875072
PMC: 9975754.
DOI: 10.3389/fimmu.2023.994520.
Shortened duration whole body F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.
van Sluis J, van Snick J, Brouwers A, Noordzij W, Dierckx R, Borra R
EJNMMI Phys. 2022; 9(1):74.
PMID: 36308568
PMC: 9618000.
DOI: 10.1186/s40658-022-00504-9.
F-FDG PET/CT for the Evaluation of Therapy Response in Hormone Receptor-Positive Bone-Dominant Metastatic Breast Cancer.
Makhlin I, Korhonen K, Martin M, Gillman J, Schubert E, Pantel A
Radiol Imaging Cancer. 2022; 4(6):e220032.
PMID: 36269154
PMC: 9713595.
DOI: 10.1148/rycan.220032.
Variations induced by body weight and background lesion normalization in standardized uptake value estimated by F18-FDG PET/CT.
Badawe E, Abdel Gawad H, El-Nagdy M, Khalil M
Eur J Hybrid Imaging. 2022; 6(1):22.
PMID: 36224438
PMC: 9556683.
DOI: 10.1186/s41824-022-00142-5.
Predictive Biomarkers for Response and Toxicity of Induction Chemotherapy in Head and Neck Cancers.
Boguszewicz L
Front Oncol. 2022; 12:900903.
PMID: 35875133
PMC: 9299243.
DOI: 10.3389/fonc.2022.900903.
Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.
Dmytriw A, Ortega C, Anconina R, Metser U, Liu Z, Liu Z
Cancers (Basel). 2022; 14(13).
PMID: 35804877
PMC: 9264840.
DOI: 10.3390/cancers14133105.
Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.
Pantel A, Viswanath V, Muzi M, Doot R, Mankoff D
J Nucl Med. 2022; 63(4):514-521.
PMID: 35361713
PMC: 8973282.
DOI: 10.2967/jnumed.121.263519.
Heart and bladder detection and segmentation on FDG PET/CT by deep learning.
Wang X, Jemaa S, Fredrickson J, Fernandez Coimbra A, Nielsen T, De Crespigny A
BMC Med Imaging. 2022; 22(1):58.
PMID: 35354384
PMC: 8977865.
DOI: 10.1186/s12880-022-00785-7.
Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation.
Kamai T, Murakami S, Arai K, Nishihara D, Uematsu T, Ishida K
BMC Cancer. 2022; 22(1):289.
PMID: 35300626
PMC: 8931959.
DOI: 10.1186/s12885-022-09415-5.
